ストックスクリーナーアプリを入手
3.9612
0.00%
0.0012
前日終値:
$3.96
開ける：
$4.02
24時間の取引高:
198.35K
Relative Volume:
0.27
時価総額：
$502.36M
収益：
$433.14M
当期純損益:
$4.95M
株価収益率:
110.96
EPS:
0.0357
ネットキャッシュフロー:
$6.55M
1週間 パフォーマンス:
-5.71%
1か月 パフォーマンス:
-19.68%
6か月 パフォーマンス:
-7.04%
1年 パフォーマンス:
+28.99%
1日の値動き範囲:
$3.9313
$4.048
1週間の範囲:
$3.89
$4.2197
52週間の値動き範囲:
$2.6101
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
ORGO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
3.96 | 502.36M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
141.96 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.051 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.00 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.01 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-28 | 開始されました | Lake Street | Buy |
| 2024-02-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-05-24 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-11-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-08-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 開始されました | SVB Leerink | Outperform |
| 2019-08-26 | 再開されました | Credit Suisse | Outperform |
| 2019-05-02 | 開始されました | Credit Suisse | Outperform |
| 2019-04-17 | 開始されました | Oppenheimer | Outperform |
| 2019-04-11 | 開始されました | SunTrust | Buy |
すべてを表示
Organogenesis Holdings Inc (ORGO) 最新ニュース
What to expect from Organogenesis Holdings Inc. in the next 30 daysTrade Exit Report & Community Consensus Picks - newser.com
Organogenesis Holdings Inc. stock prediction for this weekJuly 2025 PreEarnings & Stock Portfolio Risk Control - newser.com
Using Python tools to backtest Organogenesis Holdings Inc. strategiesWeekly Profit Analysis & AI Forecasted Stock Moves - newser.com
What indicators show strength in Organogenesis Holdings Inc.Earnings Overview Report & Precise Trade Entry Recommendations - newser.com
Will Organogenesis Holdings Inc. stock see PE expansion2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
What the charts say about Organogenesis Holdings Inc. todayTrade Exit Summary & Detailed Earnings Play Alerts - newser.com
How buyback programs support Organogenesis Holdings Inc. (2PQ) stockMarket Volume Summary & Technical Pattern Alert System - newser.com
Should I hold or sell Organogenesis Holdings Inc. stock in 2025Weekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Organogenesis Holdings Inc. stock oversold or undervalued2025 Earnings Impact & Weekly High Momentum Picks - newser.com
Is Organogenesis Holdings Inc. trending in predictive chart modelsPortfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
Wealth Enhancement Advisory Services LLC Sells 9,075 Shares of Organogenesis $ORGO - Defense World
Does Organogenesis Holdings Inc. fit your quant trading model2025 Trading Recap & Risk Controlled Stock Alerts - newser.com
Is Organogenesis Holdings Inc. stock ready for a breakout2025 Market WrapUp & High Accuracy Trade Signal Alerts - newser.com
Organogenesis (NASDAQ:ORGO) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Can trapped investors hope for a rebound in Organogenesis Holdings Inc.Trade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com
Will Organogenesis Holdings Inc. stock go up soonPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Will Organogenesis Holdings Inc. (2PQ) stock sustain bullish trend into 2025Quarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Organogenesis Holdings Inc. stock daily chart insightsWeekly Loss Report & Safe Capital Growth Tips - newser.com
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - PR Newswire
What analysts say about Organogenesis Holdings Inc 2PQ stockMarket Profile Overview & High Return Investment Ideas - earlytimes.in
Will Organogenesis Holdings Inc. continue its uptrendWall Street Watch & Verified Trade Idea Suggestions - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock considered safe havenVolume Spike & Pattern Based Trade Signal System - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock at risk of policy regulationJuly 2025 Macro Moves & Advanced Technical Signal Analysis - newser.com
Does Organogenesis Holdings Inc. qualify in momentum factor screeningTrade Analysis Report & Long-Term Safe Return Strategies - newser.com
Using portfolio simulators with Organogenesis Holdings Inc. includedWatch List & Target Return Focused Picks - newser.com
Measuring Organogenesis Holdings Inc.’s beta against major indicesPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Organogenesis $ORGO Shares Sold by Voya Investment Management LLC - Defense World
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025 - The Manila Times
Leading Regenerative Medicine Company Organogenesis to Present Q3 2025 Financial Results and Corporate Update - Stock Titan
Organogenesis Holdings Faces Setback in ReNu Phase 3 Trial - MSN
Organogenesis Holdings Inc (ORGO) 財務データ
収益
当期純利益
現金流量
EPS
Organogenesis Holdings Inc (ORGO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 05 '25 |
Buy |
2.91 |
142,379 |
413,625 |
837,437 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 04 '25 |
Buy |
2.82 |
100,863 |
284,716 |
695,058 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 06 '25 |
Buy |
2.99 |
9,022 |
26,949 |
846,459 |
1.62%
大文字化:
|
ボリューム (24 時間):